Correlation Between MaxCyte and ProSomnus, Common

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MaxCyte and ProSomnus, Common at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MaxCyte and ProSomnus, Common into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MaxCyte and ProSomnus, Common Stock, you can compare the effects of market volatilities on MaxCyte and ProSomnus, Common and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MaxCyte with a short position of ProSomnus, Common. Check out your portfolio center. Please also check ongoing floating volatility patterns of MaxCyte and ProSomnus, Common.

Diversification Opportunities for MaxCyte and ProSomnus, Common

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between MaxCyte and ProSomnus, is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding MaxCyte and ProSomnus, Common Stock in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProSomnus, Common Stock and MaxCyte is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MaxCyte are associated (or correlated) with ProSomnus, Common. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProSomnus, Common Stock has no effect on the direction of MaxCyte i.e., MaxCyte and ProSomnus, Common go up and down completely randomly.

Pair Corralation between MaxCyte and ProSomnus, Common

Given the investment horizon of 90 days MaxCyte is expected to under-perform the ProSomnus, Common. But the stock apears to be less risky and, when comparing its historical volatility, MaxCyte is 16.16 times less risky than ProSomnus, Common. The stock trades about -0.01 of its potential returns per unit of risk. The ProSomnus, Common Stock is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  490.00  in ProSomnus, Common Stock on September 2, 2024 and sell it today you would lose (443.00) from holding ProSomnus, Common Stock or give up 90.41% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy82.8%
ValuesDaily Returns

MaxCyte  vs.  ProSomnus, Common Stock

 Performance 
       Timeline  
MaxCyte 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MaxCyte has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's fundamental indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
ProSomnus, Common Stock 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ProSomnus, Common Stock has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, ProSomnus, Common is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors.

MaxCyte and ProSomnus, Common Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MaxCyte and ProSomnus, Common

The main advantage of trading using opposite MaxCyte and ProSomnus, Common positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MaxCyte position performs unexpectedly, ProSomnus, Common can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProSomnus, Common will offset losses from the drop in ProSomnus, Common's long position.
The idea behind MaxCyte and ProSomnus, Common Stock pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments